Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001319244-14-000011
Filing Date
2014-03-14
Accepted
2014-03-14 17:18:07
Documents
1
Group Members
ICS OPPORTUNITIES, LTD.INTEGRATED ASSETS II LLCINTEGRATED ASSETS, LTD.INTEGRATED CORE STRATEGIES (US) LLCISRAEL A. ENGLANDERMILLENNIUM INTERNATIONAL MANAGEMENT GP LLCMILLENNIUM INTERNATIONAL MANAGEMENT LPMILLENNIUM MANAGEMENT LLC

Document Format Files

Seq Description Document Type Size
1 ANIP_sc13g.htm SC 13G 155837
  Complete submission text file 0001319244-14-000011.txt   158045
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Subject) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-60689 | Film No.: 14695426
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O MILLENNIUM MANAGEMENT LLC 666 FIFTH AVENUE, 8TH FLOOR NEW YORK NY 10103
Business Address C/O MILLENNIUM MANAGEMENT LLC 666 FIFTH AVENUE, 8TH FLOOR NEW YORK NY 10103 (212) 841-4100
INTEGRATED CORE STRATEGIES (US) LLC (Filed by) CIK: 0001319244 (see all company filings)

EIN.: 202196675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G